Jiangsu Kanion Pharmaceutical Co. Ltd.SSE: 600557

Announcement on Convening the 2024 Annual and Q1 2025 Performance Briefing

· Issued by Jiangsu Kanion Pharmaceutical Co. Ltd. via Shanghai Stock Exchange

Filed with SSE · · 2 pages · Chinese

Release

Announcement on Convening the 2024 Annual and Q1 2025 Performance Briefing

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Jiangsu Kanion Pharmaceutical Co. Ltd. on 6ix

Earlier from Jiangsu Kanion Pharmaceutical

Later from Jiangsu Kanion Pharmaceutical

All Jiangsu Kanion Pharmaceutical news releases